Mayo Clinic PET Radiochemistry Facility
Pharmaceutical company · Rochester, Minnesota, United States
Mayo Clinic PET Radiochemistry Facility is a pharmaceutical company with a registered site in Rochester, Minnesota, United States. The US FDA lists 3 drug manufacturing or testing sites registered to the company.
Mayo Clinic PET Radiochemistry Facility at a glance
What does Mayo Clinic PET Radiochemistry Facility do?
Operations at its FDA-registered drug sites
Where is Mayo Clinic PET Radiochemistry Facility located?
Registered site: Rochester, Minnesota, United States
- Rochester, MinnesotaMayo Clinic PET Radiochemistry Facility · FDA drug site
- Phoenix, ArizonaMayo Clinic PET Radiochemistry Facility · FDA drug site
- Jacksonville, FloridaMayo Clinic PET Radiochemistry Facility · FDA drug site
Frequently asked questions about Mayo Clinic PET Radiochemistry Facility
Where is Mayo Clinic PET Radiochemistry Facility based?
Mayo Clinic PET Radiochemistry Facility is based in Rochester, Minnesota, United States.
What does Mayo Clinic PET Radiochemistry Facility do?
Mayo Clinic PET Radiochemistry Facility is a pharmaceutical company. Its FDA-registered drug sites are registered for manufacturing and PET drug production.
How many FDA-registered sites does Mayo Clinic PET Radiochemistry Facility have?
The US FDA lists 3 registered sites for Mayo Clinic PET Radiochemistry Facility.
Similar companies
- Vaccinex, Inc.Rochester, New York, United States
- Aspyron IncRochester, New York, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences